Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARIX BIOSCIENCE PLC Regulatory Filings 2017

Mar 22, 2017

4968_rns_2017-03-22_1580dc0d-4d4c-426a-b662-dc4cd9dcb9b3.html

Regulatory Filings

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2329A

Arix Bioscience Plc

22 March 2017

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer

of existing shares to which voting rights are

attached: ii
Arix Bioscience Plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights X
Other (please specify):
3. Full name of person(s) subject to the

notification obligation: iii
Woodford Investment Management Ltd (Woodford
4. Full name of shareholder(s) (if different from 3.):iv Clients of Woodford
5. Date of the transaction and date on

which the threshold is crossed or

reached: v
21/03/2017
6. Date on which issuer notified: 22/03/2017
7. Threshold(s) that is/are crossed or

reached: vi, vii
32%,31%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of

shares



if possible using

the ISIN CODE
Situation previous

to the triggering

transaction
Resulting situation after the triggering transaction
Number

of

Shares
Number

of

Voting

Rights
Number

of shares
Number of voting

rights
%of voting rightsx
Direct Direct xi Indirect xii Direct Indirect
GB00BD045071 29,538,005 29,538,005 29,538,005 29,538,005 30.74%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial

instrument
Expiration

date xiii
Exercise/

Conversion Period xiv
Number of voting

rights that may be

acquired if the

instrument is

exercised/ converted.
% of voting

rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial

instrument
Exercise price Expiration date xvii Exercise/

Conversion period xviii
Number of voting rights instrument refers to % of voting rights xix, xx
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
29,538,005 30.74 %
9. Chain of controlled undertakings through which the voting rights and/or the

financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease

to hold:
12. Date on which proxy holder will cease to hold

voting rights:
13. Additional information:
14. Contact name: Akpene Akonou
15. Contact telephone number: 01865 809024

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLJTMITMBATBBR